Medical Xpress August 21, 2024
Drugs like Ozempic and Wegovy, known as GLP-1 receptor agonists, have surged in popularity as a treatment for weight loss and management. The increase involves not only adults but also adolescents, along with bariatric surgery patients.
Michael Kochis, a resident in the Department of Surgery at Massachusetts General Hospital, realized that little research had been done regarding the use of these drugs on adolescent bariatric surgery patients.
Kochis and his team examined practice patterns across the nation, and he spoke to the Gazette about the group’s recent study published in the Journal of Surgical Research as well as safety issues for youth generally. This interview has been edited for length and clarity.
Have these drugs been found to be safe,...
Today's Sponsors
Today's Sponsor